KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelixis (EXEL) Research & Development: 2009-2025

Historic Research & Development for Exelixis (EXEL) over the last 15 years, with Jan 2025 value amounting to $910.4 million.

  • Exelixis' Research & Development fell 10.52% to $199.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $860.8 million, marking a year-over-year decrease of 5.00%. This contributed to the annual value of $910.4 million for FY2025, which is 12.80% down from last year.
  • Latest data reveals that Exelixis reported Research & Development of $910.4 million as of FY2025, which was down 12.80% from $1.0 billion recorded in FY2023.
  • Exelixis' Research & Development's 5-year high stood at $1.0 billion during FY2023, with a 5-year trough of $547.9 million in FY2021.
  • Moreover, its 2-year median value for Research & Development was $977.2 million (2023), whereas its average is $977.2 million.
  • As far as peak fluctuations go, Exelixis' Research & Development soared by 62.58% in 2021, and later decreased by 12.80% in 2025.
  • Exelixis' Research & Development (Yearly) stood at $547.9 million in 2021, then climbed by 26.62% to $693.7 million in 2021, then climbed by 28.56% to $891.8 million in 2022, then rose by 17.07% to $1.0 billion in 2023, then decreased by 12.80% to $910.4 million in 2025.